Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Mar;103(3):391–396. doi: 10.1111/j.1365-2249.1996.tb08292.x

Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

G BOUMA *, B XIA *, J B A CRUSIUS *, G BIOQUE *, I KOUTROUBAKIS *, B M E VON BLOMBERG *, S G M MEUWISSEN *, A S PEÑA *
PMCID: PMC2200378  PMID: 8608636

Abstract

In 153 patients with IBD, 64 with Crohn's disease (CD), and 89 with ulcerative colitis (UC), as well as in 54 healthy controls (HC), the frequencies of four known di-allelic polymorphisms in the genes for TNF-α and lymphotoxin alpha (LTα) were investigated. In the Dutch population, the alleles of these four polymorphisms are present in only five combinations, called TNF haplotypes: TNF-C, -E, -H, -I, -P. Furthermore, the relation with the presence of perinuclear anti-neutrophil cytoplasmic autoantibodies (P-ANCA) was studied. A small, but statistically significant, association between the polymorphism at position -308 in the promoter region of the TNF-α gene and UC was found. The frequency of the uncommon TNF-α -308 allele 2 was found to be decreased in patients with UC compared with HC (allele frequency of allele 2 in UC patients 0·15 versus 0·25 in HC, P = 0·044). No significant differences in distribution of the TNF haplotypes were found between IBD patients and HC, although there was a tendency towards a higher frequency of the TNF-C haplotype in UC patients compared with controls (haplotype frequency 22% versus 13%; P = 0·19). No statistically significant differences in distribution of the TNF haplotypes were observed between P-ANCA-positive and P-ANCA-negative UC patients. The strength of the associations indicates that TNF genes are not markers for the predisposition to suffer from IBD. They may, however, be markers of subsets of patients with UC and CD.

Keywords: inflammatory bowel disease, Crohn's disease, ulcerative colitis, HLA association, tumour necrosis factor-alpha, lymphotoxin α, gene polymorphism, haplotype

Full Text

The Full Text of this article is available as a PDF (829.1 KB).

References

  • 1.Peña AS, Crusius JBA, Oudkerk Pool M, et al. Genetics and epidemiology may contribute to understanding the pathogenesis of IBD—a new approach is now indicated. Can J Gastroenterol. 1993;7:71–75. [Google Scholar]
  • 2.Koutroubakis I, Peña AS. Genetics of inflammatory bowel disease. In: Allan RN, Keighley MRB, Alexander-Williams J, Fazio VW, Hanauer S, Rhodes JM, editors. Inflammatory bowel disease. 3. London: Churchill Livingstone; 1996. in press. [Google Scholar]
  • 3.Freidel AC, Betuel H, Gebuhrer L, Farre A, Lambert J. Cellular and serological subtypes of HLA-DR2. Tissue Antigens. 1987;29:129–40. doi: 10.1111/j.1399-0039.1987.tb01565.x. [DOI] [PubMed] [Google Scholar]
  • 4.Toyoda H, Wang SJ, Yang HY, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104:741–8. doi: 10.1016/0016-5085(93)91009-7. [DOI] [PubMed] [Google Scholar]
  • 5.Sugimura K, Asakura H, Mizuki M, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol. 1993;36:112–8. doi: 10.1016/0198-8859(93)90113-f. [DOI] [PubMed] [Google Scholar]
  • 6.Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol. 1994;89:1957–62. [PubMed] [Google Scholar]
  • 7.Futami S, Aoyama N, Honsako Y, et al. HLA-DRB1-*-1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis. Dig Dis Sci. 1995;40:814–8. doi: 10.1007/BF02064985. [DOI] [PubMed] [Google Scholar]
  • 8.Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an anti-neutrophil cytoplasmic antibody-positive subgroup. Gastroenterology. 1995;108:423–7. doi: 10.1016/0016-5085(95)90069-1. [DOI] [PubMed] [Google Scholar]
  • 9.Colombel JF, Danze PM, Jacquot S, et al. HLA class II genes and Crohn's disease: different associations in adults and children. Gastroenterology. 1995;108:A800. [Google Scholar]
  • 10.Jacob CO. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today. 1992;13:122–5. doi: 10.1016/0167-5699(92)90107-i. [DOI] [PubMed] [Google Scholar]
  • 11.Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA. 1990;87:1233–7. doi: 10.1073/pnas.87.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: a NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991;173:209–19. doi: 10.1084/jem.173.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pociot F, Mølvig J, Wogensen L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol. 1991;33:37–49. doi: 10.1111/j.1365-3083.1991.tb02490.x. [DOI] [PubMed] [Google Scholar]
  • 14.Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993;23:224–31. doi: 10.1002/eji.1830230135. [DOI] [PubMed] [Google Scholar]
  • 15.Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-beta gene detected by AspHI digest. Eur J Immunogenetics. 1992;19:425–30. doi: 10.1111/j.1744-313x.1992.tb00086.x. [DOI] [PubMed] [Google Scholar]
  • 16.Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor (TNF) alpha gene detectable by NcoI restriction of PCR product. Hum Mol Gen. 1992;1:353. doi: 10.1093/hmg/1.5.353. [DOI] [PubMed] [Google Scholar]
  • 17.Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177:557–60. doi: 10.1084/jem.177.2.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994;39:150–4. doi: 10.1007/BF00188619. [DOI] [PubMed] [Google Scholar]
  • 19.Crusius JBA, Bing X, Mulder CJJ, Mearin ML, Peña AS. Relevance of haplotypes in the TNF region in celiac disease. Eur Cytokine Network. 1994;5:168. [Google Scholar]
  • 20.Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202–10. doi: 10.1016/s0091-6749(05)80067-3. [DOI] [PubMed] [Google Scholar]
  • 21.Oudkerk Pool M, Ellerbroek P, Ridwan B, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut. 1993;34:46–50. doi: 10.1136/gut.34.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology. 1992;103:456–61. doi: 10.1016/0016-5085(92)90834-l. [DOI] [PubMed] [Google Scholar]
  • 23.Yang H, Rotter JI, Toyoda H, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA Class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest. 1993;92:1080–4. doi: 10.1172/JCI116613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Koutroubakis I, Xia B, Crusius JBA, et al. Tumor necrosis factor alpha polymorphism in inflammatory bowel disease. Hellenic J Gastroenterol. 1995;8:132–5. [Google Scholar]
  • 25.Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(Suppl. 170):2–6. doi: 10.3109/00365528909091339. [DOI] [PubMed] [Google Scholar]
  • 26.Wiik A. Delineation of a standard procedure for indirect immuno-fluorescence detection of ANCA. APMIS. 1989;97:12–13. [PubMed] [Google Scholar]
  • 27.Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut. 1994;35:696–700. doi: 10.1136/gut.35.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int. 1992;5:141–54. [Google Scholar]
  • 29.Peña AS, Meuwissen SGM. Clinical subgroups in inflammatory bowel disease. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins; 1994. pp. 272–8. [Google Scholar]
  • 30.Bouma G, Oudkerk Pool M, Scharenberg JGM, et al. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce the cytokines tumour necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol. 1995;30:1095–100. doi: 10.3109/00365529509101613. [DOI] [PubMed] [Google Scholar]
  • 31.Bouma G, Crusius JBA, Oudkerk Pool M, et al. Haplotype restricted differences in in vitro production of tumor necrosis factor alpha and lymphotoxin alpha in patients with inflammatory bowel disease and healthy controls. Gastroenterology. 1995;108:A787. doi: 10.3109/00365529509101613. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES